As of Nov 17
| 0.00 / 0.00%|
The 6 analysts offering 12-month price forecasts for BioDelivery Sciences International Inc have a median target of 4.75, with a high estimate of 5.00 and a low estimate of 4.00. The median estimate represents a +111.11% increase from the last price of 2.25.
The current consensus among 7 polled investment analysts is to Buy stock in BioDelivery Sciences International Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.